Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Oncology and Therapy
|
March 7, 2017
Network Meta-analysis of Progression-Free Survival and Overall Survival in First-Line Treatment of BRAF Mutation-Positive Metastatic Melanoma
Jordan Amdahl, Lei Chen, Thomas E Delea
Infectious Diseases and Therapy
|
November 10, 2020
Pediatric Vaccines and Cost-Effectiveness Thresholds: How Much is Too Much to Pay for Prevention?
Jordan Amdahl, Derek Weycker, Ray Farkouh, et al.
Pharmacoeconomics
|
December 10, 2014
Cost effectiveness of dabrafenib as a first-line treatment in patients with BRAF V600 mutation-positive unresectable or metastatic melanoma in Canada
Thomas E Delea, Jordan Amdahl, Alice Wang, et al.
Journal of Managed Care & Specialty Pharmacy
|
January 7, 2015
Cost-effectiveness of pazopanib versus sunitinib for renal cancer in the United States
Thomas E Delea, Jordan Amdahl, Jose Diaz, et al.
Plos One
|
June 22, 2017
Cost-effectiveness of pazopanib versus sunitinib for metastatic renal cell carcinoma in the United Kingdom
Jordan Amdahl, Jose Diaz, Arati Sharma, et al.
Journal of Managed Care & Specialty Pharmacy
|
November 6, 2015
The Authors Respond
Thomas E Delea, Jordan Amdahl, Jose Diaz, et al.
Pharmacoeconomics
|
June 21, 2019
Cost Effectiveness of Blinatumomab Versus Inotuzumab Ozogamicin in Adult Patients with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia in the United States
Thomas E Delea, Xinke Zhang, Jordan Amdahl, et al.
Sarcoma
|
July 16, 2014
Cost-effectiveness of pazopanib in advanced soft tissue sarcoma in the United kingdom
Jordan Amdahl, Stephanie C Manson, Robert Isbell, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 15, 2017
Cost-Effectiveness of Thoracic Radiation Therapy for Extensive-Stage Small Cell Lung Cancer Using Evidence From the Chest Radiotherapy Extensive-Stage Small Cell Lung Cancer Trial (CREST)
Grace I Patrice, Nataniel H Lester-Coll, James B Yu, et al.
Journal of Medical Economics
|
June 21, 2017
Cost-effectiveness of blinatumomab versus salvage chemotherapy in relapsed or refractory Philadelphia-chromosome-negative B-precursor acute lymphoblastic leukemia from a US payer perspective
Thomas E Delea, Jordan Amdahl, Diana Boyko, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Oncology and Therapy
|
March 7, 2017
Network Meta-analysis of Progression-Free Survival and Overall Survival in First-Line Treatment of BRAF Mutation-Positive Metastatic Melanoma
Jordan Amdahl, Lei Chen, Thomas E Delea
Infectious Diseases and Therapy
|
November 10, 2020
Pediatric Vaccines and Cost-Effectiveness Thresholds: How Much is Too Much to Pay for Prevention?
Jordan Amdahl, Derek Weycker, Ray Farkouh, et al.
Pharmacoeconomics
|
December 10, 2014
Cost effectiveness of dabrafenib as a first-line treatment in patients with BRAF V600 mutation-positive unresectable or metastatic melanoma in Canada
Thomas E Delea, Jordan Amdahl, Alice Wang, et al.
Journal of Managed Care & Specialty Pharmacy
|
January 7, 2015
Cost-effectiveness of pazopanib versus sunitinib for renal cancer in the United States
Thomas E Delea, Jordan Amdahl, Jose Diaz, et al.
Plos One
|
June 22, 2017
Cost-effectiveness of pazopanib versus sunitinib for metastatic renal cell carcinoma in the United Kingdom
Jordan Amdahl, Jose Diaz, Arati Sharma, et al.
Journal of Managed Care & Specialty Pharmacy
|
November 6, 2015
The Authors Respond
Thomas E Delea, Jordan Amdahl, Jose Diaz, et al.
Pharmacoeconomics
|
June 21, 2019
Cost Effectiveness of Blinatumomab Versus Inotuzumab Ozogamicin in Adult Patients with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia in the United States
Thomas E Delea, Xinke Zhang, Jordan Amdahl, et al.
Sarcoma
|
July 16, 2014
Cost-effectiveness of pazopanib in advanced soft tissue sarcoma in the United kingdom
Jordan Amdahl, Stephanie C Manson, Robert Isbell, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 15, 2017
Cost-Effectiveness of Thoracic Radiation Therapy for Extensive-Stage Small Cell Lung Cancer Using Evidence From the Chest Radiotherapy Extensive-Stage Small Cell Lung Cancer Trial (CREST)
Grace I Patrice, Nataniel H Lester-Coll, James B Yu, et al.
Journal of Medical Economics
|
June 21, 2017
Cost-effectiveness of blinatumomab versus salvage chemotherapy in relapsed or refractory Philadelphia-chromosome-negative B-precursor acute lymphoblastic leukemia from a US payer perspective
Thomas E Delea, Jordan Amdahl, Diana Boyko, et al.
Page
of 1